ArticleMolecular cancer therapeutics2024

Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts.

Yanjun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.